Vexev

Vascular Imaging Reimagined

Sydney, Australia · $14.5M raised

Headquarters
Sydney
Business Model
B2B
Website
vexev.com
Total Funding
$14.5M
Last Round
$6.0M Venture RoundAug 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Vexev is an Australian-based medical device company developing the VxWave Ultrasound Imaging System, a robotic tomographic ultrasound system designed for upper limb vascular imaging that integrates advanced robotics, machine learning, and ultrasound signal processing to create a 3D vascular model at the point of care. In a multi-center feasibility study called the CANSCAN trial (NCT06691672), conducted with U.S. Renal Care, Vexev enrolled 120 chronic kidney disease patients to evaluate semi-autonomous ultrasound scanning for arteriovenous (AV) fistula mapping in dialysis clinics.

Summary

Vexev is a Healthcare company based in Sydney, Australia. It has raised $14.5M in total across 2 rounds, most recently a $6.0M Venture Round in Aug 2026. Investors include Blackbird Ventures, NeoTribe Ventures and Startmate.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2026
$6.0M

Sign up to see all 2 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vexev on Indexed.vc
<a href="https://indexed.vc/companies/vexev"><img src="https://indexed.vc/api/badge/company/vexev" alt="Vexev on Indexed.vc" width="260" height="76" /></a>